# Vanderbilt Clinical Oncology Research Career Development Award

> **NIH NIH K12** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2024 · $702,458

## Abstract

PROJECT SUMMARY
The Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP) provides junior faculty
conducting patient-oriented research in cancer with the tools and experience to design and implement
hypothesis-driven research and effectively lead cancer research projects. This program is a cornerstone of the
Vanderbilt Ingram Cancer Center (VICC), and its activities are embedded across the entire VICC enterprise,
training leading investigators from every specialty related to cancer. This program ensures that we develop a
strong and diverse pipeline of emerging investigators who have the skills necessary to drive impactful
programs, and who have been accelerated in their trajectory by multidisciplinary and community-engaged
focused learning. The primary components of VCORCDP are mentored clinical research in oncology coupled
with tailored didactic training that may lead to a Master of Science in Clinical Investigation or other approved
individualized educational pathway and group skill development, with exposure to the breadth of cancer
research. Our mentors are a diverse group of 39 committed, experienced faculty. Scholars conduct research
across the cancer care continuum in one of three domains: 1) Clinical Trials and Drug Development, 2)
Translational Cancer Biology, and 3) Cancer Health Outcomes and Epidemiology. Through regular meetings
with the Program Directors, peer scholars, and mentorship committees, as well as preparation of Individual
Development Plans and structured Progress Reports, VCORCDP scholars tailor their career development to
be able to address the most relevant and meaningful issues in their field. The program is co-led by two
physician scientists, a medical oncologist who conducts translational research and a pediatric oncologist who
conducts population science and clinical research. An Internal Advisory Committee representing the diversity
of VCORCDP research evaluates the progress of individual scholars and the program’s success. Metrics
include diversity of program participants, program completion, retention in research-focused careers, funding
success, publication, and impact. An External Advisory Committee, composed of a cancer epidemiologist, a
community representative, and four oncology physician-scientists, provides input into the scientific direction of
program, ensures it is meeting national workforce needs and cancer priorities, and monitors progress,
accomplishments, and trajectory to further programmatic advancement. Fifty-six scholars have entered the
VCORCDP since its inception, 57% male and 43% female. As of June 2021, seven scholars (12%) represent
URiM groups. Our 56 scholars have published over 1,800 manuscripts over their careers to date. Of the 50
scholars who have graduated, 45 (90%) continue in research-intensive careers, and 38 of the 45 (84%) have
peer-reviewed grant support, including clinical trials. The VCORCDP is poised to continue to successfully
develop investigators to le...

## Key facts

- **NIH application ID:** 10880413
- **Project number:** 5K12CA090625-24
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Debra L. Friedman
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $702,458
- **Award type:** 5
- **Project period:** 2001-09-21 → 2027-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10880413

## Citation

> US National Institutes of Health, RePORTER application 10880413, Vanderbilt Clinical Oncology Research Career Development Award (5K12CA090625-24). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10880413. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*